DETERMINATION OF THE DIFFERENCES BETWEEN RALOXIFEN AND RISEDRONATE TREATMENT ON BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN POSTMENOPAUSAL OSTEOPOROSIS

被引：0
|
作者：
Yeter, A. [1 ]
Kavuncu, V. [1 ]
Evcik, D. [2 ]
Demirdal, U. S. [1 ]
机构：
[1] Afyon Kocatepe Univ, Dept Phys Med & Rehabil, Fac Med, Afyon, Turkey
[2] Ufuk Univ, Fac Med, Dept Phys Med & Rehabil, Ankara, Turkey
来源：
OSTEOPOROSIS INTERNATIONAL | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [31] Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis
    Vasikaran, Samuel D.
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2008, 45 (02) : 221 - 258
  • [32] Monitoring osteoporosis therapy: Bone mineral density, bone turnover markers, or both?
    Bonnick, SL
    Shulman, L
    [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04): : 25S - 31S
  • [33] Bone mineral density, bone turnover markers and osteoporosis in patients with thalassemia major
    Ardawi, M. S.
    Qari, M. H.
    [J]. BONE, 2007, 40 (06) : S193 - S193
  • [34] RELATIONSHIP BETWEEN REDUCTION IN BONE TURNOVER MARKERS (BTM) AND CHANGE IN BONE MINERAL DENSITY (BMD) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS TREATED WITH DENOSUMAB
    Eastell, R.
    Christiansen, C.
    Grauer, A.
    Kutilek, S.
    Libanati, C.
    McClung, M.
    Resch, H.
    Siris, E.
    Uebelhart, D.
    Reid, I.
    Wang, A.
    Weryha, G.
    Cummings, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 185 - 186
  • [35] Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis
    Li, Mei
    Zhang, Zhen-lin
    Liao, Er-yuan
    Chen, De-cai
    Liu, Jian
    Tao, Tian-zun
    Wu, Wen
    Xia, Wei-bo
    Lu, Yu-juan
    Sheng, Zhi-feng
    Lu, Chun-yan
    Meng, Guo-ling
    Xu, Liang
    Zhang, Wei-jie
    Hu, Ying-ying
    Xu, Ling
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (01): : 72 - 78
  • [36] The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis
    Szulc, Pawel
    [J]. CLINICAL BIOCHEMISTRY, 2012, 45 (12) : 907 - 919
  • [37] The relationships between bone turnover markers and bone mineral density in postmenopausal type 2 diabetic women
    Klimontov, Vadim V.
    Fazullina, Olga N.
    Lykov, Alexander P.
    Konenkov, Vladimir I.
    [J]. DIABETES MELLITUS, 2016, 19 (05): : 375 - 382
  • [38] Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    Michalska, D.
    Luchavova, M.
    Zikan, V.
    Raska, I., Jr.
    Kubena, A. A.
    Stepan, J. J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 (12) : 2885 - 2891
  • [39] Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    D. Michalska
    M. Luchavova
    V. Zikan
    I. Raska
    A. A. Kubena
    J. J. Stepan
    [J]. Osteoporosis International, 2012, 23 : 2885 - 2891
  • [40] Combination therapy of curcumin an alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
    Khanizadeh, Fatemeh
    Rahmani, Asghar
    Asadollahi, Khairollah
    Ahmadi, Mohammad Reza Hafezi
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 438 - 445
12345